Keyphrases
Graft-versus-host Disease (GvHD)
100%
Acute Myeloid Leukemia
64%
Selinexor
27%
T Cells
22%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
22%
Dendritic Cells
21%
Endothelial Cells
20%
MicroRNA-155 (miR-155)
19%
MicroRNA
19%
Donor T Cell
18%
XPO1 Inhibitor
14%
Novel Therapeutic Targets
14%
Antileukemic Activity
13%
DLK1
13%
Decitabine
13%
T Cell Immunity
13%
Antitumor T Cells
13%
Phase 1 Study
13%
Mantle Cell Lymphoma
13%
Protein Arginine Methyltransferase 5 (PRMT5)
13%
XPO1
11%
Exportin-1
10%
Relapsed or Refractory Acute Myeloid Leukemia
9%
Hematological Malignancies
9%
Nuclear Export Inhibitors
9%
Programmed Death-ligand 1 (PD-L1)
9%
CD8+
8%
Nucleophosmin 1 (NPM1)
8%
Tolerability
8%
Chemotherapy
8%
Chemotherapy Response
7%
Notch Signaling
7%
Thrombotic Microangiopathy
7%
Murine Model
7%
EGFL7
7%
Selective Inhibitor
7%
Lethality
7%
Confidence Interval
7%
Interleukin-17 (IL-17)
7%
Interferon Response
6%
Salvage Chemotherapy
6%
TTreg
6%
MiR-146b
6%
Notch Ligands
6%
HLA-matched Donor
6%
Epidermal Growth Factor
6%
Complement-mediated Thrombotic Microangiopathy
6%
Effector Function
6%
Inhibitory Potency
6%
Functional Consequences
6%
Immunology and Microbiology
Acute Graft Versus Host Disease
51%
T Cell
49%
Myeloid
42%
Graft-Versus-Host Disease
35%
Dendritic Cell
16%
Epidermal Growth Factor
13%
Hematopoietic Cell
9%
Cell Proliferation
9%
Knockout Mouse
8%
Interleukin 17
8%
CD8
8%
Hematopoiesis
7%
Memory T Cell
7%
Regulatory T Cell
7%
Notch Signaling
7%
Cell Line
7%
Adoptive Immunity
7%
Tumor Necrosis Factor Receptor
6%
Clustered Regularly Interspaced Short Palindromic Repeat
6%
T Cell Receptor
6%
Programmed Death 1 Ligand 1
6%
Lymphoma Cell
6%
Autoantibodies
6%
CD38
6%
interferon
6%
Toll-Like Receptor
6%
Notch
6%
Quantitative Trait Locus
6%
Host
6%
Somatic Hypermutation
6%
Single Nucleotide Polymorphism
6%
Agonist
6%
Cell Expansion
6%
Allogeneic Hematopoietic Stem Cell Transplantation
6%
Allogeneic Bone Marrow Transplantation
6%
Arginine
6%
Gene Expression
6%
Cell Activation
5%
Medicine and Dentistry
Acute Myeloid Leukemia
33%
Graft Versus Host Reaction
21%
T Cell
16%
Cellular Immunity
13%
Dendritic Cell
13%
Selinexor
13%
Notch
13%
Neoplasm
13%
Malignant Neoplasm
9%
Notch Signaling
7%
Nuclear Export
7%
Acute Graft Versus Host Disease
7%
Chemotherapy
6%
Endothelial Cell
6%
Pirfenidone
6%
Chronic Graft Versus Host Disease
6%
DNA Topoisomerase (ATP Hydrolysing)
6%
DNA Repair
6%
4 Iodo 2,5 Dimethoxyamphetamine
6%
Programmed Death 1 Ligand 1
6%
Clustered Regularly Interspaced Short Palindromic Repeat
6%
Synapsin I
6%
Immunotherapy
6%
Drive
6%
Breathing
6%
microRNA 15a
6%
Transplantation
6%
microRNA 155
6%
Cas9
6%
Microangiopathy
6%
Lethality
6%
Clinical Trial
5%
